Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: Earlier detection of a poor prognostic cancer subtype?

Acta Cytologica

Volumn 55, Issue 3, 2011, Pages 255-260

  Skaznik Wikiel, Malgorzata E ^a   Ueda, Stefanie M ^c   Frasure, Heidi E ^b   Rose, Peter G ^a   Fleury, Aimee ^c   Grumbine, Francis C ^c   Fader, Amanda Nickles ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

Cervical cytology; Endometrial cancer; Papanicolaou smear; Uterine papillary serous carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CLEAR CELL CARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PAPANICOLAOU TEST; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CYTOLOGY; UTERINE PAPILLARY SEROUS CARCINOMA; UTERUS CARCINOMA; CONGENITAL MALFORMATION; CYSTADENOCARCINOMA; CYTOLOGY; ENDOMETRIUM TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX; VAGINA SMEAR;

AGED; AGED, 80 AND OVER; CERVIX UTERI; CYSTADENOCARCINOMA; CYTOLOGICAL TECHNIQUES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; VAGINAL SMEARS;

EID: 79960901771     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000324052     Document Type: Article

References (22)

1. Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE: Pap smears in women with endometrial carcinoma. Acta Cytol 2001; 45: 555-560.
2. Kuebler DL, Nikrui N, Bell DA: Cytologic features of endometrial papillary serous carcinoma. Acta Cytol 1989; 33: 120-126.
3. Todo Y, Minobe S, Okamoto K, Takeda M, Ebina Y, et al: Cytological features of cervical smears in serous adenocarcinoma of the endometrium. Jpn J Clin Oncol 2003; 33: 636-641.
4. Park JY, Kim HS, Hong SR, Chun YK: Cytologic findings of cervicovaginal smears in women with uterine papillary serous carcinoma. J Korean Med Sci 2005; 20: 93-97.
5. Van Doom HC, Opmeer BC, Kooi GS, Ewing- Graham PC, Kruitwagen RF, Mol BW: Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding. Acta Cytol 2009; 53: 277-282.
6. Creasman WT, Eddy GL: Recent advances in endometrial cancer. Semin Surg Oncol 1990; 6: 339-342.
7. DuBeshter B, Warshal DP, Angel C, Dvoretsky PM, Lin JY, Raubertas RF: Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol 1991; 77: 458-462.
8. Larson DM, Johnson KK, Reyes CN Jr, Broste SK: Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol 1994; 84: 399-403.
9. Zhao C, Florea A, Onisko A, Austin RM: Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol 2009; 114: 383-389.
10. Mitchell H, Giles G, Medley G: Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol 1993; 12: 34-40.
11. Briley M, Lindsell DR: The role of transvaginal ultrasound in the investigation of women with post-menopausal bleeding. Clin Radiol 1998; 53: 502-505.
12. Karlsson B, Granberg S, Wikland M, Ylostalo P, Torvid K, Marsal K, et al: Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - a Nordic multicenter study. Am J Obstet Gynecol 1995; 172: 1488-1494.
13. Davidson KG, Dubinsky TJ: Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin North Am 2003; 41: 769-780.
14. Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH: Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol 2006; 101: 120-125.
15. Kipp BR, Medeiros F, Campion MB, Distad TJ, Peterson LM, Keeney GL, et al: Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia. Cancer 2008; 114: 228-235.
16. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C: American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin 2002; 52: 342.
17. ACOG Committee on Practice Bulletins - Gynecology: Practice Bulletin no. 109: cervical cytology screening. Obstet Gynecol 2009; 114: 1409-1420.
18. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK: Efficacy of systemic pelvic lymphadencetomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 2009; 373: 125-136.
19. Fader AN, Starks D, Gehrig PA, Secord AA, Frasure HE, O'Malley DM, et al: An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol 2009; 115: 244-248.
20. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, Cain JM, Tamimi HK, Figge DC, Greer BE: Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994; 54: 264-268.
21. Bristow RE, Asrari F, Trimble EL, Montz FJ: Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease. Gynecol Oncol 2001; 81: 279-286.
22. Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, Gehrig PA, Tuller E, Axtell AE, Zanotti KM: Platinum/ taxane-based chemotherapy with or without radiotherapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer 2009; 115: 2119-2127.